Most gastrointestinal side effects improve significantly after the body adjusts to the medication
12,13 As the incidence of IIH is rising 1416 in line with global obesity trends, 17 targeted treatments are an unmet clinical need
Full studies available on PubMed
Dokken BB, Hilwig WR, Teachey MK, Panchal RA, Hubner K, Allen D, Rogers DC, Kern KB: Glucagon-like peptide-1 (GLP-1) attenuates post-resuscitation myocardial microcirculatory dysfunction
It's important to remain vigilant for symptoms of biliary complications such as jaundice (yellowing of skin/eyes), dark urine, or pale stools, as GLP-1 receptor agonists can increase the risk of biliary events even in those without a gallbladder
Conversely, food containing more energy from carbs and fat and less from protein and fibre tends to encourage eating more, especially when combined with ultra-processed foods